Prognostic value of free triiodothyronine in patients with dilated cardiomyopathyOACSCDCSTPCD
Prognostic value of free triiodothyronine in patients with dilated cardiomyopathy
Hong-Yan Zhao;Ling Sun;Ye-Qian Zhu;Qiu-Shi Chen;Wen-Wu Zhu;Mohammad Bilaal Toorabally;Xin-Guang Chen;Feng-Xiang Zhang
Section of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, ChinaDepartment of Cardiology, The Affiliated Changzhou No.2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu 213003, ChinaSection of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, ChinaSection of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, ChinaSection of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, ChinaVictoria Hospital, Candos, MauritiusSection of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, ChinaSection of Pacing and Electrophysiology, Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China
Dilated cardiomyopathyFree triiodothyronineAll-cause mortality
Dilated cardiomyopathyFree triiodothyronineAll-cause mortality
《中华医学杂志(英文版)》 2020 (18)
2170-2176,7
This study was funded by grants from the National Key Research and Development Program of China (No.2016YFE0117000),the National Natural Science Foundation of China (Nos.81901410,81871113),Qinghai Provincial Natural Science Fund (No.2017-ZJ-769),333 project of Jiangsu Province (No.BRA2017544),and Changzhou Science and Technology Bureau (No.CJ20190102).
评论